Cardiovascular events associated with thalidomide and prednisone in leprosy type 2 reaction

• Main Authors: Melissa de Almeida Corrêa Alfredo (Author), Juliano Vilaverde Schmitt (Author), Anna Carolina Miola (Author), Simone de Pádua Milagres (Author), Joel Carlos Lastoria (Author)
• Formato: Libro
• Publicado: Sociedade Brasileira de Dermatologia, 2024-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Abstract Background: Thalidomide is the drug of choice for the treatment of type 2 leprosy reactions and is often associated with corticosteroids. The use of these drugs in multiple myeloma is associated with the risk of cardiovascular events, but there have been few studies assessing this risk in l...